v3.19.3
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Income Statement [Abstract]        
Revenue $ 0 $ 0 $ 0 $ 0
Operating expenses:        
Research and development 2,430,503 1,717,113 3,660,236 3,804,015
Sales and marketing 33,166 109,565 136,845 178,115
Depreciation and amortization 73,347 30,028 146,095 90,321
General and administrative 1,763,597 794,991 5,719,568 2,078,191
Total operating expenses 4,300,613 2,651,697 9,662,744 6,150,642
Loss from operations (4,300,613) (2,651,697) (9,662,744) (6,150,642)
Other (expense) income:        
Interest expense 0 (327,978) (822,858) (747,492)
Interest income 5,716 1,054 8,826 2,760
Total other (expense) income 5,716 (326,924) (814,032) (744,732)
Net loss (4,294,897) (2,978,621) (10,476,776) (6,895,374)
Dividend to series A and B preferred stockholders 0 (320,000) (160,219) (960,000)
Net loss attributable to common stockholders $ (4,294,897) $ (3,298,621) $ (10,636,995) $ (7,855,374)
Net loss per common share, basic and diluted (in dollars per share) $ (0.27) $ (1.74) $ (0.83) $ (4.23)
Weighted average number of common shares outstanding, basic and diluted (in shares) 15,994,002 1,898,056 12,877,047 1,855,190

Source